Engineering resistance to 'aging' of phosphylated human acetylcholinesterase. Role of hydrogen bond network in the active center. 1993

A Ordentlich, and C Kronman, and D Barak, and D Stein, and N Ariel, and D Marcus, and B Velan, and A Shafferman
Department of Biochemistry, Israel Institute for Biological Research, Ness-Ziona.

Recombinant human acetylcholinesterase (HuAChE) and selected mutants (E202Q, Y337A, E450A) were studied with respect to catalytic activity towards charged and noncharged substrates, phosphylation with organophosphorus (OP) inhibitors and subsequent aging of the OP-conjugates. Amino acid E450, unlike residues E202 and Y337, is not within interaction distance from the active center. Yet, the bimolecular rates of catalysis and phosphylation are 30-100 fold lower for both E450A and E202Q compared to Y337A or the wild type and in both mutants the resulting OP-conjugates show striking resistance to aging. It is proposed that a hydrogen bond network, that maintains the functional architecture of the active center, involving water molecules and residues E202 and E450, is responsible for the observed behaviour.

UI MeSH Term Description Entries
D007531 Isoflurophate A di-isopropyl-fluorophosphate which is an irreversible cholinesterase inhibitor used to investigate the NERVOUS SYSTEM. DFP,Diisopropylfluorophosphate,Fluostigmine,Bis(1-methylethyl) Phosphorofluoridate,Di-isopropylphosphorofluoridate,Diisopropylphosphofluoridate,Dyflos,Floropryl,Fluorostigmine,Di isopropylphosphorofluoridate
D007700 Kinetics The rate dynamics in chemical or physical systems.
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D011806 Quinolinium Compounds Compounds, Quinolinium
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002800 Cholinesterase Inhibitors Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. Acetylcholinesterase Inhibitor,Acetylcholinesterase Inhibitors,Anti-Cholinesterase,Anticholinesterase,Anticholinesterase Agent,Anticholinesterase Agents,Anticholinesterase Drug,Cholinesterase Inhibitor,Anti-Cholinesterases,Anticholinesterase Drugs,Anticholinesterases,Cholinesterase Inhibitors, Irreversible,Cholinesterase Inhibitors, Reversible,Agent, Anticholinesterase,Agents, Anticholinesterase,Anti Cholinesterase,Anti Cholinesterases,Drug, Anticholinesterase,Drugs, Anticholinesterase,Inhibitor, Acetylcholinesterase,Inhibitor, Cholinesterase,Inhibitors, Acetylcholinesterase,Inhibitors, Cholinesterase,Inhibitors, Irreversible Cholinesterase,Inhibitors, Reversible Cholinesterase,Irreversible Cholinesterase Inhibitors,Reversible Cholinesterase Inhibitors
D004795 Enzyme Stability The extent to which an enzyme retains its structural conformation or its activity when subjected to storage, isolation, and purification or various other physical or chemical manipulations, including proteolytic enzymes and heat. Enzyme Stabilities,Stabilities, Enzyme,Stability, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006860 Hydrogen Bonding A low-energy attractive force between hydrogen and another element. It plays a major role in determining the properties of water, proteins, and other compounds. Hydrogen Bonds,Bond, Hydrogen,Hydrogen Bond

Related Publications

A Ordentlich, and C Kronman, and D Barak, and D Stein, and N Ariel, and D Marcus, and B Velan, and A Shafferman
April 1983, Die Pharmazie,
A Ordentlich, and C Kronman, and D Barak, and D Stein, and N Ariel, and D Marcus, and B Velan, and A Shafferman
September 1996, The Biochemical journal,
A Ordentlich, and C Kronman, and D Barak, and D Stein, and N Ariel, and D Marcus, and B Velan, and A Shafferman
April 1977, Biochemical pharmacology,
A Ordentlich, and C Kronman, and D Barak, and D Stein, and N Ariel, and D Marcus, and B Velan, and A Shafferman
October 1967, Biochemical pharmacology,
A Ordentlich, and C Kronman, and D Barak, and D Stein, and N Ariel, and D Marcus, and B Velan, and A Shafferman
September 1999, The Journal of biological chemistry,
A Ordentlich, and C Kronman, and D Barak, and D Stein, and N Ariel, and D Marcus, and B Velan, and A Shafferman
September 2010, Chemico-biological interactions,
A Ordentlich, and C Kronman, and D Barak, and D Stein, and N Ariel, and D Marcus, and B Velan, and A Shafferman
September 2010, Chemico-biological interactions,
A Ordentlich, and C Kronman, and D Barak, and D Stein, and N Ariel, and D Marcus, and B Velan, and A Shafferman
February 1970, Philosophical transactions of the Royal Society of London. Series B, Biological sciences,
A Ordentlich, and C Kronman, and D Barak, and D Stein, and N Ariel, and D Marcus, and B Velan, and A Shafferman
March 2014, Journal of the American Chemical Society,
A Ordentlich, and C Kronman, and D Barak, and D Stein, and N Ariel, and D Marcus, and B Velan, and A Shafferman
November 2013, Journal of synchrotron radiation,
Copied contents to your clipboard!